This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 13 print issues and online access
$259.00 per year
only $19.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Hong S-J, Vogelstein JT, Gozzi A, Bernhardt BC, Yeo BTT, Milham MP, et al. Toward neurosubtypes in autism. Biol Psychiatry. 2020;88:111–28.
Buch AM, Liston C. Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. Neuropsychopharmacology. 2021;46:156–75.
Buch AM, Vértes PE, Seidlitz J, Kim SH, Grosenick L, Liston C. Molecular and network-level mechanisms explaining individual differences in autism spectrum disorder. Nat Neurosci. 2023;26:650–63.
Gandal MJ, Haney JR, Wamsley B, Yap CX, Parhami S, Emani PS, et al. Broad transcriptomic dysregulation occurs across the cerebral cortex in ASD. Nature. 2022;611:532–9.
Parellada M, Andreu-Bernabeu Á, Burdeus M, San José Cáceres A, Urbiola E, Carpenter LL, et al. In search of biomarkers to guide interventions in autism spectrum disorder: a systematic review. Am J Psychiatry. 2023;180:23–40.
Antaki D, Guevara J, Maihofer AX, Klein M, Gujral M, Grove J, et al. A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex. Nat Genet. 2022;54:1284–92.
AMB was supported by a Ford Foundation Postdoctoral Fellowship. Additionally, this work was supported by grants from the NIMH (MH118388, MH114976, MH123154, MH118451, MH109685, and MH109685-04S1), the National Institute on Drug Abuse (DA047851), the Hope for Depression Research Foundation, the Pritzker Neuropsychiatric Disorders Research Consortium, the Klingenstein–Simons Foundation Fund, the One Mind Institute, the Rita Allen Foundation, the Dana Foundation, the Foundation for OCD Research, the Hartwell Foundation, and the Brain and Behavior Research Foundation (NARSAD).
CL is listed as an inventor for Cornell University patent applications on neuroimaging biomarkers for depression that are pending or in preparation. CL has served as a scientific advisor or consultant to Compass Pathways, Delix Therapeutics, and Brainify.AI. The authors declare no other competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Buch, A.M., Liston, C. Gene–brain–behavior mechanisms underlying autism spectrum disorder: implications for precision psychiatry. Neuropsychopharmacol. (2023). https://doi.org/10.1038/s41386-023-01722-0